发明名称 PROGRAMMED CELL DEATH AND INTERLEUKIN-1 beta
摘要 Methods for modulating programmed cell death are provided. Apoptosis, induced by a variety of stimuli, can be inhibited by blocking IL-1 beta binding to its type-1 receptor. Additionally, IL-1 beta had anti-apoptotic activity when added exogenously prior to exposure to apoptotic stimuli. ICE cleavage of pro-IL-1 beta is an important step in apoptosis, and mature IL-1 beta may function as a positive or negative mediator of cell death.
申请公布号 WO9733606(A1) 申请公布日期 1997.09.18
申请号 WO1996US03468 申请日期 1996.03.15
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 YUAN, JUNYING;FRIEDLANDER, ROBERT
分类号 A61K45/00;A61K31/00;A61K38/00;A61K38/20;A61K39/395;A61P43/00;C07K16/24;(IPC1-7):A61K38/20 主分类号 A61K45/00
代理机构 代理人
主权项
地址